Advertisement
Advertisement
CVS
CVS HEALTH CORPORATION
97.65
USDSponsored
-0.46
-0.47%
May 14, 12:10 UTC -4
Open
CVS Earnings Reports
Positive Surprise Ratio
CVS beat 39 of 41 last estimates.
95%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$101.16B
/$1.83
Implied change from Q1 26 (Revenue/ EPS)
+0.73%
/-28.79%
Implied change from Q2 25 (Revenue/ EPS)
+2.27%
/+1.10%
CVS HEALTH CORPORATION earnings per share and revenue
On May 06, 2026, CVS reported earnings of 2.57 USD per share (EPS) for Q1 26, beating the estimate of 2.21 USD, resulting in a 15.80% surprise. Revenue reached 100.43 billion, compared to an expected 96.05 billion, with a 4.56% difference. The market reacted with a +7.65% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 20 analysts forecast an EPS of 1.83 USD, with revenue projected to reach 101.16 billion USD, implying an decrease of -28.79% EPS, and increase of 0.73% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
PACS Group, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
$0.40
Actual
$0.50
Surprise
+22.55%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
Enhabit, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
$0.15
Actual
-Surprise
-
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.05
Surprise
+38.88%
COMPASS Pathways Plc - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.38
Actual
-$0.30
Surprise
+22.20%
SBC Medical Group Holdings Incorporated Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.09
Actual
$0.11
Surprise
+11.11%
Shoulder Innovations, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.42
Actual
-$0.41
Surprise
+3.10%
DocGo Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.09
Actual
-$0.12
Surprise
-26.05%
NeuroOne Medical Technologies Corporation Common Stock
Report Date
May 12, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.25
Surprise
-8.13%
IceCure Medical Ltd. Ordinary Shares
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-26.05%
FAQ
What were CVS HEALTH CORPORATION's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, CVS HEALTH CORPORATION reported EPS of $2.57, beating estimates by 15.8%, and revenue of $100.43B, 4.56% above expectations.
How did the market react to CVS HEALTH CORPORATION's Q1 2026 earnings?
The stock price moved up 7.65%, changed from $80.69 before the earnings release to $86.86 the day after.
When is CVS HEALTH CORPORATION expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for CVS HEALTH CORPORATION's next earnings report?
Based on 20
analysts, CVS HEALTH CORPORATION is expected to report EPS of $1.83 and revenue of $101.16B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement